Amrize Ltd
AMRZ · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.46 | -0.02 | 1.17 | -1.16 |
| FCF Yield | 2.49% | 0.62% | -3.71% | 5.71% |
| EV / EBITDA | 32.48 | 38.13 | 175.01 | 47.03 |
| Quality | ||||
| ROIC | 2.76% | 2.39% | -0.06% | 1.91% |
| Gross Margin | 29.55% | 30.00% | 10.67% | 27.27% |
| Cash Conversion Ratio | 1.57 | 0.95 | 9.84 | 5.91 |
| Growth | ||||
| Revenue 3-Year CAGR | 22,782,347.76% | 22,634,321.66% | 22,649,276.47% | 22,704,373.62% |
| Free Cash Flow Growth | 291.23% | 116.03% | -164.94% | 308.71% |
| Safety | ||||
| Net Debt / EBITDA | 5.98 | 7.38 | 29.89 | 5.70 |
| Interest Coverage | 8.70 | 5.53 | -0.30 | -4.59 |
| Efficiency | ||||
| Inventory Turnover | 1.71 | 1.37 | 1.16 | 1.43 |
| Cash Conversion Cycle | 56.68 | 64.30 | 77.03 | 40.68 |